The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

WEINSTEIN ROBERT

Reporting owner CIK 0001213709 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.WEINSTEIN ROBERTWEINSTEIN ROBERTWEINSTEIN ROBERT · April 25, 2025 · Stock award · Stock Option (Right to Buy)WEINSTEIN ROBERT · December 12, 2025 · Stock award · Common StockWEINSTEIN ROBERT · August 6, 2025 · Stock award · Employee Stock Option (right to buy)WEINSTEIN ROBERT · October 17, 2025 · Stock award · Common Stock, par value $0.0001 per shareApr 25, 2025Dec 12, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Apr 25, 2025PharmaCyte Biotech, Inc.Stock Option (Right to Buy)WEINSTEIN ROBERTStock award
Dec 12, 2025PharmaCyte Biotech, Inc.Common StockWEINSTEIN ROBERTStock award
Aug 6, 2025TAO Synergies Inc.Employee Stock Option (right to buy)WEINSTEIN ROBERTStock award
Oct 17, 2025TAO Synergies Inc.Common Stock, par value $0.0001 per shareWEINSTEIN ROBERTStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PharmaCyte Biotech, Inc.PMCB · company listingsStock awardStock Option (Right to Buy)Derivative security · Code A63,2330Value: 0Currency not specifiedView ↗
Trade: PharmaCyte Biotech, Inc.PMCB · company listingsStock awardCommon StockNon-derivative security · Code A75,0000Value: 0Currency not specifiedView ↗
Trade: TAO Synergies Inc.TAOX · company listings
WEINSTEIN ROBERTChief Financial Officer
Stock awardEmployee Stock Option (right to buy)Derivative security · Code A7,0000Value: 0Currency not specifiedView ↗
Trade: TAO Synergies Inc.TAOX · company listings
WEINSTEIN ROBERTChief Financial Officer
Stock awardCommon Stock, par value $0.0001 per shareNon-derivative security · Code A10,0000Value: 0Currency not specifiedView ↗